Additionally, PD-1 and PD-L1 blockade significantly increased the CD8+ to Tregs and CD4+ to Tregs ratios within the tumor, while, on the contrary, there was no significant change in the CD8+ or CD4+ to Tregs ratios (25). The gene discussed is CD8A; the disease is neoplasm.